![Katia Schlienger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katia Schlienger worked as the Chief Medical Officer at HOOKIPA Pharma, Inc. from 2021 to 2023.
Prior to this, she earned a doctorate degree from Saint Louis University School of Medicine and Universite Paris Cite.
| Sociétés | Poste | Fin |
|---|---|---|
| HOOA PHARPAR | Directeur Technique/Scientifique/R&D | 30/09/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
